LABD vs VXUS
Direxion Daily S&P Biotech Bear 3X ETF vs Vanguard Total International Stock ETF
Quick Verdict
VXUS has a lower expense ratio. VXUS delivered stronger 1-year returns. VXUS offers more diversification with 8,747 holdings.
Side-by-Side Comparison
| Metric | LABD | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | 1.07% | 0.05% | |
| AUM | $61M | $158.1B | |
| Dividend Yield | 4.50% | 2.59% | |
| Holdings | 10 | 8,747 | |
| YTD Return | -71.57% | +15.52% | |
| 1Y Return | -89.11% | +26.73% | |
| 3Y Return (annualized) | -66.00% | +20.35% | |
| 5Y Return (annualized) | -48.86% | +9.40% | |
| Volatility (annualized) | 87.6% | 15.1% | |
| Max Drawdown | -100.0% | -39.9% | |
| Fund Family | Direxion Shares ETF Trust | Vanguard (US) | |
| Category | Alternative | Equity | |
| Inception | May 28, 2015 | Jan 26, 2011 |
LABD vs VXUS Performance
Direxion Daily S&P Biotech Bear 3X ETF (LABD) is a ETF from Direxion Shares ETF Trust and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year LABD returned -89.11% while VXUS returned +26.73%. Year to date, LABD is down 71.57% versus a gain of 15.52% for VXUS.
Over three years, LABD compounded at -66.00% per year against +20.35% for VXUS; over five years the annualized figures are -48.86% and +9.40% respectively. Across the full 11-year window we track, VXUS has the edge at +4.90% annualized vs -56.65%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
LABD has been the more volatile fund, with annualized monthly volatility of 87.6% compared with 15.1% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -100.0% for LABD and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at -0.48. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
LABD charges 1.07% per year while VXUS charges 0.05%. On a $10,000 position that is $107 vs $5 annually, a gap of $102 per year that compounds over a long holding period. On income, LABD currently yields 4.50% against 2.59% for VXUS.
Holdings Overlap
LABD and VXUS share 0 holdings out of 7873 unique holdings combined, representing a 0.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, LABD or VXUS?
LABD has an expense ratio of 1.07% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $102 per year of difference.
Which performed better, LABD or VXUS?
Over the past year LABD returned -89.11% vs +26.73% for VXUS, so VXUS leads on 1-year performance. Over the longest common window we track (11 years), LABD annualized -56.65% vs +4.90% for VXUS. Past performance does not guarantee future results.
Which is riskier, LABD or VXUS?
LABD has been the more volatile fund at 87.6% annualized versus 15.1% for VXUS. Worst drawdown: LABD -100.0% vs VXUS -39.9%.
Should I hold both LABD and VXUS?
LABD and VXUS have a monthly-return correlation of -0.48, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between LABD and VXUS?
LABD and VXUS share 0 common holdings with a 0.0% weight overlap. Combined, they hold 7873 unique securities.
Which pays a higher dividend, LABD or VXUS?
LABD yields 4.50% while VXUS yields 2.59%, so LABD currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.